Profil
Karin Eklund Vanderpol is currently Vice President-Regulatory Affairs at Vicore Pharma Holding AB since 2022.
Former positions include Director-Global Regulatory Affairs at Swedish Orphan Biovitrum AB, Head-Regulatory Affairs at AstraZeneca AB, and Head-Regulatory Affairs at Oncopeptides AB from 2020 to 2022.
Education includes a graduate degree from the University of Uppsala.
Postes actifs de Karin Eklund Vanderpol
| Sociétés | Poste | Début |
|---|---|---|
| VICORE PHARMA HOLDING AB | Conseiller Juridique Général | 01/01/2022 |
Anciens postes connus de Karin Eklund Vanderpol
| Sociétés | Poste | Fin |
|---|---|---|
| ONCOPEPTIDES AB | Conseiller Juridique Général | 01/01/2022 |
| SWEDISH ORPHAN BIOVITRUM AB | Conseiller Juridique Général | 01/12/2019 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Conseiller Juridique Général | - |
Formation de Karin Eklund Vanderpol
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Uppsala
University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Vicore Pharma Holding AB
Vicore Pharma Holding AB Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for lung diseases | Health Technology |
















